Zygel, a topical cannabidiol medication developed by Zynerba Pharmaceuticals, reduced irritability in children with fragile X, a common genetic cause of autism. Zygel, a topical cannabidiol medication developed by Zynerba Pharmaceuticals, reduced irritability in children with fragile X, a common genetic cause of autism. Read More   

By